LRRK2 and Parkinson disease: Using baseline and annual change rates in longitudinal data obtained using DAT SPECT from sPD, LRRK2-G2019S-PD, and GBA1-N370S-PD patients, Lee et al. tried to predict the temporal trajectory of putaminal dopaminergic dysfunction during the premotor phase.